CSPI urges FDA to overrule advisory panel on peptides
The consumer advocacy group's appeal targets a panel recommendation on peptide products; no further detail was published with the item.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 14 16:03 ETSource: Center for Science in the Public Interest
The wire
- 01The Center for Science in the Public Interest publicly called on FDA to overrule an advisory panel decision concerning peptides.
- 02Advisory committee recommendations feed directly into FDA category decisions that determine which peptides compounders may legally prepare.
- 03The underlying panel recommendation, the specific peptides at issue and FDA's response are not detailed in the item.
From the source
Read at cspi.orgPeptides: FDA urged to overrule advisory panel
